University of Groningen Translational research into oral colon-specific drug delivery Schellekens, Reinout Cornelus Andreas IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2011 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Schellekens, R. C. A. (2011). Translational research into oral colon-specific drug delivery: from laboratory to clinic Groningen: s.n. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 14-08-2017
Appendix 3 List of publications
Peer reviewed journals (pharmaceutical practice): 2003 : Research paper Giesen EAA, Schellekens RCA, Herder R, Uges DRA, Stability of adenosine 5 -monophosphate solutions for inhalation. EJHP 2003; 4: 63-67. 2007 : Practice paper Alffenaar JWC, Heiden J van der, Herder RE, Greijdanus B, Uges DRA, Schellekens RCA, Rapid development of pharmacy-prepared labetalol injection as the solution for Trandate drug discontinuity. EJHP, 2007. 2007 : Practice paper P.V. Nannan Panday, J.H. van der Heiden, J. Dillingh, R.J. Wijdh, J.G.W. Kosterink, R.C.A. Schellekens, Microbiologische validatie van de snap-cap oogdruppelflacon: de casus acetylcysteine 5%-oogdruppels. PW/WP, 2007. 2009 : Practice paper E.C.F. Dijkers, J.G.W. Kosterink, R.C.A Schellekens, Verlengde houdbaarheid oxaliplatine infuus? PW/WP 2009; 16. 2009 : Practice paper J.M. Maurer, S. Kouwenhoven, K. Brouwers, H.J. Woerdenbag, J.G.W. Kosterink, R.C.A. Schellekens, Farmacotherapeutische rationaliteit van apotheekbereidingen: evaluatie en toepasbaarheid van de LNA-procedure Farmacotherapeutische plaatsbepaling apotheekbereiding. PW/WP 2009; 3(11): 217-222. 2009 : Practice paper J.M. Maurer, J.H. Dillingh, J. van der Heiden, D.R.A. Uges, A.F. Bos, J.G.W. Kosterink, R.C.A. Schellekens, Ontwikkeling van een glucose-calcium infusievloeistof voor premature neonaten, PW/WP 2009; 30/31: 135-141. 2010 : Practice paper H.M. van Rieke, D. Croonen, R.J. Wijdh, R.C.A. Schellekens, Farmacotherapeutische plaatsbepaling van oculair toegediend tacrolimus bij extraoculaire niet-infectieuze oogziekten. PW/WP 2010; 4(7): 150-153. 2010 : Practice paper Herman J. Woerdenbag, Jan H. Dillingh, Jacquelien T.M. Wanders, E. Jildau Boer, Henderik W. Frijlink, Jos G.W. Kosterink, Reinout C.A. Schellekens, Elastomeer infuuspompen getest voor de praktijk. PW/WP, accepted 2011 : Practice paper Linda Labberton, Renella E Herder, Mathieu S Bolhuis, Reinout CA Schellekens, Donald RA Uges, Formulation of a tacrolimus suspension with extended expiry date using raw materials. EJHP, submitted. & Peer reviewed journals (pharmaceutical or medical research): 2006 : Research paper Schellekens RCA, Stuurman FE, Van der Weert FHJ, Kosterink JGW, Frijlink HW, A dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products. EJPB, Eur J Pharm Sci. 2007; Jan;30(1):15-20. Epub 2006 Okt 4. Appendix 205
2008 : Research paper Schellekens RCA, Stellaard F, Mitrovic D, Stuurman FE, Kosterink JGW, Frijlink HW;.Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in ph-responsive polymer coatings, JCR, 2008; Epub 2008 Aug 23. 2009 : Research paper Schellekens RCA, Olsder G, Langenberg SMCH, Frijlink HW, Kosterink JGW, Stellaard F., The application of 13 C-urea as a marker substance for the assessment of in vivo behaviour of oral colon-targeted dosage forms, BJP, 2009; 158: 532-540. 2010 : Research paper R.C.A. Schellekens, F. Stellaard, G.G. Olsder, H.J. Woerdenbag, H.W. Frijlink, J.G.W. Kosterink, Oral ileocolonic drug delivery by the colopulse-system; a bioavailability study in healthy volunteers, JCR 2010; 146(3): 334-340. 2010 : Research paper R.C.A. Schellekens, J.H. Baltink, E.M. Woesthuis, F. Stellaard, J.G.W. Kosterink, H.J. Woerdenbag, H.W. Frijlink, Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics, Pharm Dev Technol. 2010 Oct 5. [Epub ahead of print]. 2010 : Research paper R.H.J. Bandsma, M. Mendel, M. Spoelstra, DJ Reijngoud, T Boer, F. Stellaard, B. Brabin, R.C.A. Schellekens, E. Senga, G.T. Heikens, Decreased endogenous glucose production in children with kwashiorkor compared to marasmus is not related to impaired hepatic mitochondrial function, Ped Res, 2010; 68(5): 423-428. 2010 : Research paper Maurer JM, Schellekens R.C.A., Wutzke KM, Dijkstra G, Woerdenbag HJ, Frijlink HW, Kosterink JGW, Stellaard F, A non-invasive, low-cost study design to determine the release profile of colon drug delivery systems: a feasibility study, submitted. 2011 : Review R.C.A. Schellekens, F. Stellaard, H. J. Woerdenbag, H.W. Frijlink, J.G.W. Kosterink, Stable isotopes in clinical pharmacology, submitted. Abstract or poster: 2005 : Abstract Schellekens RCA, Stuurman FE, Frijlink HW, Kosterink JGW, Ontwikkeling van een orale toedieningsvorm met colon-specifieke afgifte ten behoeve van onderzoek naar de etiologie van lactose intolerantie, PW, 2005. 2008 : Abstract Croonen D, Van Rieke HM, Schellekens RCA, Wijdh RJ, Tacrolimus bij allergische conjuntivitis, NOG Wetenschapsdag, 2008. 2008 : Poster E. Woesthuis, A. Dubois, R.C.A. Schellekens, Permeability of the coating of a biconvex tablet, RuG 2008. 2008 : Poster Schellekens RCA, Olsder G, Langenberg SMCH, Frijlink HW, Kosterink JGW, Stellaard F., The application of 13 C-urea as a marker substance for the assessment of in vivo behaviour of oral colon-targeted dosage forms, NVZA Wetenschapsdag, 2008. 206
2010 : Abstract R.C.A. Schellekens, Olsder GG, M Maurer, JGW Kosterink, HJ Woerdenbag, KD Wutzke, HW Frijlink, F Stellaard, 13 C-urea and 15 N-urea: elegant markers to define location and kinetics of in vivo release from a colon-targeted delivery device in men, EJCI 2010; 40 (Suppl 1): 24-91. Books / Theses / Reports / Guidelines / Position papers: 1994 : Report Schellekens RCA, Research report: Electrostatic properties of Torpedo californica acetylcholinesterase Comparison with human butylcholinesterase, UCSD, School of Medicine, San Diego, 1994. 1994 : Scriptie Schellekens RCA, Doctoraalscriptie: Octrooien en Geneesmiddelen, Utrecht, 1994. 2005 : Patent Schellekens RCA, Frijlink HW, Patent: ph-controlled pulsatile delivery system, methods for preparation and use thereof, WO2007/13794 A1. 2006 : Guideline Commissie GMP-Z (Boom F, Schellekens RCA), Verwervingsbeleid apotheekbereidingen en halffabrikaten, Oktober 2006. 2006 : Guideline Projectgroep Aseptische Bereidingen (Pluim M, Boom F, Postma D, Linssen C, Schellekens RCA, Timmer J), Eindrapportage aseptische bereidingen in de ziekenhuisapotheek, Oktober 2006. 2006 : Position paper Commissie GMP-Z (Schellekens RCA), Is voor het voor-toedieninggereed-maken van studiemedicatie een fabrikantenvergunning vereist?, November 2006. 2006 : Report Liem TBY, Schellekens RCA, Midyear Clinical Meeting of the American Society of Health-system pharmacists, Congress report, EJHP Practice 2006; 12 (2): 90-91. 2009 : Book Y. Bouwman-Boer, R.C.A. Schellekens, H1: Apotheekbereiding in de geneesmiddelenvoorziening, In: Recepteerkunde productzorg en bereiding van geneesmiddelen, Ed 5, 2009. H. Vromans, R.C.A. Schellekens, H17: Ontwerpen van geneesmiddelen, In: Recepteerkunde productzorg en bereiding van geneesmiddelen, Ed 5, 2009. 2011 Position paper R.C.A. Schellekens, F. Stellaard, The regulatory status of stable isotopes in clinical research. & Appendix 207